Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Diabetic ketoacidosis (DKA) and cerebral edema are major causes of morbidity and mortality in children with diabetes mellitus.1,2 Despite greater awareness and reports of earlier detection, approximately one-third of US children with new-onset diabetes at the time of diagnosis present with DKA,3 which is defined by the presence of hyperglycemia (blood glucose [BG] level >200 mg/dL [to convert to millimoles per liter, multiply by 0.0555]), a venous pH less than 7.3 or a bicarbonate level less than 15 mEq/L (to convert to millimoles per liter, multiply by 1), and the presence of ketonemia or ketonuria.4 Initial therapy consists of fluid resuscitation and initiation of an insulin drip; however, there is longstanding controversy regarding the optimal insulin-starting dose for the management of DKA in the pediatric population.
Granados A, Lee JM. Insulin Therapy for the Management of Diabetic Ketoacidosis: Time for a Paradigm Shift? JAMA Pediatr. 2014;168(11):990–991. doi:10.1001/jamapediatrics.2014.1635
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: